This NIH SBIR Phase II Bridge Award (R44) grant is for small business concerns previously funded by NIH SBIR Phase II awards in cancer-related fields. The purpose is to accelerate the commercialization of cancer therapeutics, imaging technologies, interventional devices, and diagnostics/prognostics. This funding aims to facilitate the transition of promising projects to market by encouraging partnerships with third-party investors or strategic partners. Applicants must submit a commercialization plan detailing secured or anticipated independent third-party funding that equals or exceeds the requested NIH funds. Projects may involve preclinical or clinical stages of technology development. This initiative supports the crucial capital-intensive steps needed to bring new cancer products and technologies to the market.
Opportunity ID: 50958
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-10-009 |
Funding Opportunity Title: | SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 05, 2010 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 01, 2010 |
Current Closing Date for Applications: | Mar 01, 2010 |
Archive Date: | Apr 01, 2010 |
Estimated Total Program Funding: | $10,000,000 |
Award Ceiling: | $1,000,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded by NIH SBIR Phase II awards. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between NIHs SBIR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and technologies. Thus, applicants responding to this FOA must provide a commercialization plan that includes details of any independent third-party investor funding that has already been secured or is anticipated during the Bridge Award project period. It is expected that the level of this independent third-party funding will equal or exceed the NCI funds being requested throughout the Phase II Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required. Mechanism of Support. This FOA will utilize the NIH Small Business Innovation Research Phase II (R44) competing renewal mechanism, referred to in this FOA as the SBIR Phase II Bridge Award. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of up to ten projects awarded as a result of this announcement is $10,000,000 for fiscal year 2010. Future year amounts will depend on annual appropriations. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-10-009.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00015836 | Feb 01, 2010 | Mar 01, 2010 | View |
Package 1
Mandatory forms
50958 RR_SF424_1_2-1.2.pdf
50958 SBIR_STTR_Information_1_1-1.1.pdf
50958 PerformanceSite_1_3-1.3.pdf
50958 RR_OtherProjectInfo_1_2-1.2.pdf
50958 RR_KeyPersonExpanded_1_2-1.2.pdf
50958 RR_Budget-1.1.pdf
50958 PHS398_CoverPageSupplement_1_4-1.4.pdf
50958 PHS398_ResearchPlan_1_3-1.3.pdf
50958 PHS398_Checklist_1_3-1.3.pdf
Optional forms
50958 PHS_CoverLetter_1_2-1.2.pdf
50958 RR_SubawardBudget-1.2.pdf